• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒2型感染中的儿科胃肠道疾病:流行病学及临床意义

Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications.

作者信息

Al-Beltagi Mohammed, Saeed Nermin Kamal, Bediwy Adel Salah, El-Sawaf Yasser

机构信息

Department of Pediatric, Faculty of Medicine, Tanta University, Tanta 31527, Algharbia, Egypt.

Microbiology Section, Pathology Department, Salmaniya Medical Complex, Manama 12, Bahrain.

出版信息

World J Gastroenterol. 2021 Apr 28;27(16):1716-1727. doi: 10.3748/wjg.v27.i16.1716.

DOI:10.3748/wjg.v27.i16.1716
PMID:33967552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8072196/
Abstract

The coronavirus disease 2019 (COVID-19) pandemic is a threat worldwide for individuals of all ages, including children. Gastrointestinal manifestations could be the initial presenting manifestation in many patients, especially in children. These symptoms are more common in patients with severe disease than in patients with non-severe disease. Approximately 48.1% of patients had a stool sample that was positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA. Children typically form 1%-8% of all laboratory-confirmed cases of SARS-CoV-2. Gastrointestinal manifestations of COVID-19 in children are not rare, with a prevalence between 0 and 88%, and a wide variety of presentations, including diarrhoea, vomiting, and abdominal pain, can develop before, with or after the development of respiratory symptoms. Atypical manifestations such as appendicitis or liver injury could also appear, especially in the presence of multisystem inflammatory disease. In this review, we discussed the epidemiology of COVID-19 gastrointestinal diseases in children as well as their implications on the diagnosis, misdiagnosis, prognosis, and faecal-oral transmission route of COVID-19 and the impact of gastrointestinal diseases on the gut microbiome, child nutrition, and disease management.

摘要

2019年冠状病毒病(COVID-19)大流行对包括儿童在内的所有年龄段的个人都是一种全球威胁。胃肠道表现可能是许多患者,尤其是儿童的初始表现。这些症状在重症患者中比非重症患者更常见。约48.1%的患者粪便样本严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒RNA呈阳性。儿童通常占所有实验室确诊的SARS-CoV-2病例的1%-8%。COVID-19在儿童中的胃肠道表现并不罕见,患病率在0%至88%之间,在呼吸道症状出现之前、同时或之后,可能出现包括腹泻、呕吐和腹痛在内的多种表现。还可能出现阑尾炎或肝损伤等非典型表现,尤其是在存在多系统炎症性疾病的情况下。在本综述中,我们讨论了儿童COVID-19胃肠道疾病的流行病学,以及它们对COVID-19的诊断、误诊、预后和粪-口传播途径的影响,以及胃肠道疾病对肠道微生物群、儿童营养和疾病管理的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37e2/8072196/4d06871b870f/WJG-27-1716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37e2/8072196/4d06871b870f/WJG-27-1716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37e2/8072196/4d06871b870f/WJG-27-1716-g001.jpg

相似文献

1
Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications.新型冠状病毒2型感染中的儿科胃肠道疾病:流行病学及临床意义
World J Gastroenterol. 2021 Apr 28;27(16):1716-1727. doi: 10.3748/wjg.v27.i16.1716.
2
Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review.儿科 COVID-19 患者的胃肠道表现:从发病机制到临床管理的全面综述。
World J Gastroenterol. 2021 Jun 21;27(23):3303-3316. doi: 10.3748/wjg.v27.i23.3303.
3
Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in children.儿童 COVID-19 的胃肠道、肝脏和胰腺表现。
Clin Res Hepatol Gastroenterol. 2022 Apr;46(4):101818. doi: 10.1016/j.clinre.2021.101818. Epub 2021 Oct 2.
4
COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?新型冠状病毒肺炎与胃肠道:是感染源还是仅仅是感染新型冠状病毒后炎症过程的靶点?
World J Gastroenterol. 2021 Apr 14;27(14):1406-1418. doi: 10.3748/wjg.v27.i14.1406.
5
Paediatric COVID-19 and the GUT.儿童新冠病毒感染与肠道
Indian J Med Microbiol. 2020 Jul-Dec;38(3 & 4):261-264. doi: 10.4103/ijmm.IJMM_20_331.
6
Gastrointestinal coronavirus disease 2019 manifestations in childhood.儿童 2019 年冠状病毒病胃肠道表现。
Curr Opin Clin Nutr Metab Care. 2022 May 1;25(3):195-202. doi: 10.1097/MCO.0000000000000825. Epub 2022 Feb 23.
7
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.新型冠状病毒肺炎患者胃肠道及肝脏受累的表现和预后:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-678. doi: 10.1016/S2468-1253(20)30126-6. Epub 2020 May 12.
8
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.综述文章:COVID-19 的胃肠道特征和粪便传播的可能性。
Aliment Pharmacol Ther. 2020 May;51(9):843-851. doi: 10.1111/apt.15731. Epub 2020 Mar 31.
9
Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management.新型冠状病毒肺炎疫情期间的胃肠道和肝脏疾病:表现、机制与处理。
World J Gastroenterol. 2021 Jul 28;27(28):4504-4535. doi: 10.3748/wjg.v27.i28.4504.
10
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.COVID-19 大流行:胃肠道的病理生理学和表现。
World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. doi: 10.3748/wjg.v26.i31.4579.

引用本文的文献

1
Altered Gut Microbiota and Predicted Immune Dysregulation in Early Childhood SARS-CoV-2 Infection.幼儿感染新冠病毒后肠道微生物群的改变及预测的免疫失调
Microorganisms. 2025 Aug 12;13(8):1879. doi: 10.3390/microorganisms13081879.
2
Clinical management and complications of acute appendicitis in 3 children with SARS-CoV-2 infection: Case report.3 例 SARS-CoV-2 感染儿童急性阑尾炎的临床处理及并发症:病例报告。
Medicine (Baltimore). 2024 Oct 25;103(43):e40105. doi: 10.1097/MD.0000000000040105.
3
Fecal shedding of SARS-CoV-2 in infants born to SARS-CoV-2 positive mothers: a pilot study.

本文引用的文献

1
Gastrointestinal manifestations of COVID-19 in children: a systematic review and meta-analysis.儿童新型冠状病毒肺炎的胃肠道表现:一项系统评价与荟萃分析
Frontline Gastroenterol. 2020 Aug 18;12(4):332-337. doi: 10.1136/flgastro-2020-101529. eCollection 2021.
2
Barriers for resuming endoscopy service in the context of COVID-19 pandemic: A multicenter survey from Egypt.在 COVID-19 大流行背景下恢复内窥镜服务的障碍:来自埃及的一项多中心调查。
World J Gastroenterol. 2020 Nov 21;26(43):6880-6890. doi: 10.3748/wjg.v26.i43.6880.
3
Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective Study.
母亲感染 SARS-CoV-2 后所生婴儿粪便中 SARS-CoV-2 的排出:一项初步研究。
PeerJ. 2024 Aug 27;12:e17956. doi: 10.7717/peerj.17956. eCollection 2024.
4
Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons.粪便钙卫蛋白在儿童胃肠道疾病中的利弊
World J Clin Pediatr. 2024 Jun 9;13(2):93341. doi: 10.5409/wjcp.v13.i2.93341.
5
Impact of COVID-19 on Pediatric Inflammatory Bowel Diseases-From Expectations to Reality.新冠病毒病对儿童炎症性肠病的影响——从期望到现实
J Pers Med. 2024 Apr 9;14(4):399. doi: 10.3390/jpm14040399.
6
Descriptive Epidemiology of Pathogens Associated with Acute Respiratory Infection in a Community-Based Study of K-12 School Children (2015-2023).一项针对K-12学龄儿童的社区研究(2015 - 2023年)中与急性呼吸道感染相关病原体的描述性流行病学
Pathogens. 2024 Apr 19;13(4):340. doi: 10.3390/pathogens13040340.
7
COVID-19-induced gastrointestinal autonomic dysfunction: A systematic review.新型冠状病毒肺炎所致胃肠自主神经功能障碍:一项系统综述
World J Clin Cases. 2023 Aug 6;11(22):5252-5272. doi: 10.12998/wjcc.v11.i22.5252.
8
Acute Appendicitis Following COVID-19 Infection in Pediatric Patients: A Single Center's Study in Greece.儿童患者新冠病毒感染后急性阑尾炎:希腊单中心研究
Diagnostics (Basel). 2023 Jun 15;13(12):2070. doi: 10.3390/diagnostics13122070.
9
Liver injury in COVID-19: Clinical features, potential mechanisms, risk factors and clinical treatments.新型冠状病毒肺炎相关肝损伤:临床特征、潜在机制、危险因素及临床治疗
World J Gastroenterol. 2023 Jan 14;29(2):241-256. doi: 10.3748/wjg.v29.i2.241.
10
The Gut Microbiome of Children during the COVID-19 Pandemic.新冠疫情期间儿童的肠道微生物群
Microorganisms. 2022 Dec 13;10(12):2460. doi: 10.3390/microorganisms10122460.
与COVID-19患者不良预后相关的胃肠道症状:一项回顾性研究。
Front Med (Lausanne). 2020 Nov 11;7:608259. doi: 10.3389/fmed.2020.608259. eCollection 2020.
4
SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role.SARS-CoV-2 微生物失调相关疾病及可能的益生菌作用。
Biomed Pharmacother. 2021 Jan;133:110947. doi: 10.1016/j.biopha.2020.110947. Epub 2020 Nov 11.
5
The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19.益生菌和益生元在预防和治疗新型冠状病毒肺炎中的潜在应用。
NPJ Sci Food. 2020 Oct 5;4:17. doi: 10.1038/s41538-020-00078-9. eCollection 2020.
6
Gastrointestinal symptoms and fecal nucleic acid testing of children with 2019 coronavirus disease: a systematic review and meta-analysis.儿童 2019 冠状病毒病的胃肠道症状和粪便核酸检测:系统评价和荟萃分析。
Sci Rep. 2020 Oct 20;10(1):17846. doi: 10.1038/s41598-020-74913-0.
7
Is a healthy microbiome responsible for lower mortality in COVID-19?健康的微生物群是否是新冠病毒肺炎死亡率较低的原因?
Biologia (Bratisl). 2021;76(2):819-829. doi: 10.2478/s11756-020-00614-8. Epub 2020 Oct 15.
8
COVID-19 and intestinal inflammation: Role of fecal calprotectin.2019冠状病毒病与肠道炎症:粪便钙卫蛋白的作用
Dig Liver Dis. 2020 Nov;52(11):1231-1233. doi: 10.1016/j.dld.2020.09.015. Epub 2020 Sep 22.
9
Gastrointestinal Symptoms in Severe COVID-19 Children.严重 COVID-19 患儿的胃肠道症状。
Pediatr Infect Dis J. 2020 Oct;39(10):e317-e320. doi: 10.1097/INF.0000000000002843.
10
Covid-19: UK studies find gastrointestinal symptoms are common in children.新冠疫情:英国研究发现胃肠道症状在儿童中很常见。
BMJ. 2020 Sep 7;370:m3484. doi: 10.1136/bmj.m3484.